4 reduce I/R-induced SCI in rats by inhibiting neutrophil activation through enhancement of sensory neuron activation.
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Introduction
Paraplegia is a serious complication that occurs following surgical repair of thoracoabdominal aortic aneurysms (Gilling-Smith et al., 1995) . This complication has been attributed to temporary or permanent ischemia of the spinal cord caused by interruption of the blood supply during aortic cross-clamping (Gilling-Smith et al., 1995) . Dissection, rupture, and prolonged clamp times are closely related to an increased incidence of paraplegia (Lintott et al., 1998) . Recently, it has been shown that neutrophils play a central role in development of the pathologic condition of ischemia/reperfusion (I/R)-induced tissue injury (Bednar et al., 1997) .
We previously demonstrated that physiological anticoagulants, such as activated protein C (Hirose et al., 2000) and antithrombin (Hirose et al., 2004) , reduce I/R-induced SCI in rats by inhibiting neutrophil activation.
Carpertide, a synthetic alpha-human atrial natriuretic peptide (ANP), was isolated and identified in 1984 by Kangawa and Matsuo (Kangawa and Matsuo, 1984) . Since ANP decreases preload and afterload by diuresis (Maack et al., 1984; Ishihara et al., 1985) and induces vasodilation (Wedel and Garbers, 2001) , it has been mainly used for improvement of cardiac function in treatment of heart failure (Kikuchi et al., 2001 ) and in postoperative management of cardiac surgery (Tsuneyoshi et al., 2004) . Although recent studies have demonstrated that ANP reduces I/R-induced cardiac injury by increasing nitric oxide (NO)
production (Okawa et al., 2003) , its therapeutic mechanism(s) is not fully understood.
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J P E T # 1 2 0 7 2 5 6 Capsaicin-sensitive sensory neurons are nociceptive neurons that are activated by a wide variety of noxious physical and chemical stimuli (Dray, 1995) . On activation, sensory neurons release calcitonin gene-related peptide (CGRP), a neuropeptide that has potent vasodilatory activity (Bull et al., 1996) . Since ablation of the sensory fibers can result in a marked increase in severity of inflammation (Szallasi and Blumberg, 1996) and inflammatory responses in CGRP knockout mice subjected to hepatic I/R are markedly enhanced (Harada et al., 2006) , sensory neurons might play a role in the maintenance of tissue integrity by attenuating inflammatory responses (Okajima and Harada, 2006) . We demonstrated that CGRP increases endothelial production of PGI 2 via activation of both endothelial nitric oxide synthase (eNOS) and cyclooxygenase (COX)-1 in rats subjected to hepatic I/R, thereby reducing I/R-induced liver injury through inhibition of neutrophil activation (Harada et al., 2002) .
We recently reported that CGRP reduces the severity of compression-induced SCI in rats by inhibiting neutrophil activation through the promotion of endothelial PGI 2 production (Kitamura et al., 2007) . Thus, it is possible that I/R-induced activation of sensory neurons in the spinal cord reduces I/R-induced SCI by inhibiting neutrophil activation.
Since neutrophils are critically involved in the development of I/R-induced cardiac injury (Vinten-Johansen, 2004) , it is possible that ANP reduces I/R-induced SCI by inhibiting neutrophil activation. We hypothesized that ANP might enhance CGRP release from sensory neurons in the spinal cord, thereby increasing endothelial production of NO and PGI 2 , both of This article has not been copyedited and formatted. The final version may differ from this version.
J P E T # 1 2 0 7 2 5 7 which are capable of inhibiting neutrophil activation directly or indirectly (Okajima et al., 2004) . In the present study, we examined this possibility using a rat model of I/R-induced SCI.
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METHODS

Materials
Carperitide (α-human atrial natriuretic peptide: ANP) was the generous gift of Daiichi Pharmaceutical Co. (Tokyo, Japan). KT5720, an inhibitor of PKA, was purchased from Alexis (Basel, Switzerland). Indomethacin (IM), a non-selective inhibitor of COX, SB366791, a specific vanilloid receptor-1 antagonist (Varga et al., 2005) , and capsazepine (CPZ), an inhibitor of vanilloid receptor-1 activation (Perkins and Campbell, 1992) , were purchased from Sigma. (St. Louis, MO). All other reagents were of analytical grade.
Preparation of various agents
ANP was dissolved in sterile distilled water. KT5720 was dissolved in 10% Tween 20/10% methanol (10%) with normal saline. IM was suspended in bicarbonate-buffered saline.
SB366791 was dissoleved in dimethyl sulfoxide (1%) with normal saline. CPZ was dissolved in 10% Tween 20/10% ethanol (10%) with normal saline. Solutions were prepared immediately before the experiments. Each saline-treated SCI animal received the vehicle in these experiments. However, because results in control experiments using the vehicle of each solution were not significantly different from those obtained by using saline (data not shown).
Therefore, we used as a representative control the data obtained by using saline in the present study.
Animals
The study protocol was approved by the Nagoya City University Animal Care and Use committee. The care and handling of the animals were conducted in accordance with the guidelines of the National Institutes of Health.
Adult pathogen-free male SD rats (Nihon SLC, Hamamatsu, Japan) weighting 300 to 350 g were used in the experiments.
Isolation and culture of dorsal root ganglion neurons (DRG) and measurement of CGRP in culture and cAMP measurement
DRG isolated from the lumbar, cervical and thoracic region were dissected from rats as described previously (Harada et al., 2006) . In brief, DRG were placed in ice-cold sterile calcium-and magnesium-free Dulbecco's phosphate buffered saline (PBS) (Gibco, Grand
Island, NY, USA). Ganglia were chopped and incubated at 37°C for 15 minutes in Dulbecco's PBS containing 20 U/ml papain (Worthington Biochemical Corporation, Lakewood, NJ, USA).
The tissue was then incubated at 37°C for 15 minutes in Dulbecco's PBS containing 4 mg/ml collagenase type II (Worthington Biochemical Corporation). The tissue was incubated for a further 30 minues in Dulbecco's PBS containing 2,000 U/ml dispase I (Godo Shusei, Tokyo, Japan) at 37°C. Individual cells were then dissociated by trituration through a fire-polished This article has not been copyedited and formatted. The final version may differ from this version. Ham's F-12 medium containing 10% supplemented calf serum (SCS), 2 mM glutamine and 50 ng/mL mouse 2.5S nerve growth factor (NGF) (Upstate Biotecnology, Lake Placid, NY, USA).
After 24 hours, the culture medium was removed and replaced every 2 days.
After 5 days in culture, the medium was aspirated gently and washed with serum free
Ham's F-12 medium (Hyclone, Logan, UT). Cells were incubated with ANP (1, 10, and 100 nM) for 30 minutes in Ham's F-12 medium containing 1% SCS without NGF. After incubation, supernatants were sampled and stored -20°C for CGRP measurement. To determine whether ANP increase CGRP release from DRG via vanilloid receptor-1 activation, we examined the effect of CPZ, an inhibitor of vanilloid receptor-1 activation (Perkins and Campbell, 1992) , on ANP-induced CGRP release from DRG. CGRP levels were determined using a commercial rat CGRP enzyme immunometric assay kit (SPI-Bio, Massy, France) . Recent studies demonstrated that cAMP plays a critical role in CGRP release from sensory neurons by phosphorylating vanilloid receptor-1 through activation of PKA (Mohapatra and Nau, 2003) and cAMP-dependent PKA activation is critically involved in CGRP production in DRG (Hou and Wang, 2001) . Therefore, we measured the intracellular cAMP levels in DRG. We examined the effect of KT5720 on CGRP release from DRG at a concentration of 10 µM as described 
Evaluation of Survival and Neurologic Status
To evaluate the effect of ANP on survival, animals were allowed to survive for 21 days.
Animals that never recovered completely from the surgery and then died within 24 hours after reperfusion were excluded from the analyses. The motor function of rats was assessed in a masked manner using the Tarlov's scale and the inclined-plane test as described previously (Hirose et al., 2000; Hirose et al., 2004) . The Tarlov's motor scale is as follows: 0, no voluntary movement (complete paraplegia); 1, perceptible movement at the joint; 2, good joint mobility but inability to stand; 3, ability to stand and walk; and 4, complete recovery. For the inclined-plane test, we used a smooth-surface inclined plane, and the maximum inclination of the plane at which rats could maintain themselves for 5 seconds without falling from the plane was recorded.
This article has not been copyedited and formatted. The final version may differ from this version. 
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Histopathologic Examination of the Spinal Cord
The lumbar enlargement of the spinal cord under the L1 vertebra was harvested and postfixed in the fixative overnight. Transverse section 5 µm thick, paraffin-embedded sections were prepared and stained with hematoxylin and eosin. When significant injury was present, motor neuron cells in the ventral gray matter showed eosinophilic, structureless cytoplasm and loss of nuclear hematoxylin stainability (Hirose et al., 2000) . The cells were considered viable if they demonstrated basophilic stippling. The total number of intact motor neurons in the ventral gray matter region was counted using five serial sections of each animal.
Measurement of Spinal Cord Tumor Necrosis Factor levels
Spinal cord levels of tumor necrosis factor (TNF) were determined by a modification as the methods described previously (Hirose et al., 2000) . In brief, after the indicated time period of reperfusion, spinal cords were removed, immediately plunged into liquid nitrogen for rapid freezing, and stored at -80°C for later biochemical analysis. TNF concentration was measured at five segmental levels (cervical, upper thoracic, lower thoracic, lumber, and sacral segments).
The frozen sample was weighed and homogenized ( Since we have previously demonstrated that levels of TNF in spinal cord tissue are increased after I/R, peaking at 3 hours of reperfusion (Hirose et al., 2000) , we measured the spinal cord TNF levels 3 hours after reperfusion in this study.
Assay of Myeloperoxidase Levels in Spinal Cord Tissue
Spinal cord levels of myeloperoxidase (MPO) were determined by a modification as the methods described previously (Hirose et al., 2000) . In brief, the frozen samples was weighed, homogenized (1:10, w/v) in 0.1 M phosphate buffer (pH 6.0) containing 0.5% hexadecyltrimethyl ammonium bromide (Sigma) in ice bath and sonicated for 30 seconds.
After centrifugation (4500 x g at 4°C for 20 minutes), the supernatant was assayed for MPO activity. The assay started by adding 0.1 mL sample to 0.6 mL 0.1 M phosphate buffer (pH 6.0) containing 1.25 mg/mL o-dianisidine and 0.05% hydrogen peroxide. The change in absorbance at 460 nm after 20 minutes was measured using spectrophotometer (DU-54; Beckman, Irvine, CA) and the MPO activity in each sample was calculated using a standard curve prepared using purified MPO. We measured the spinal cord MPO levels at 24 hours after reperfusion as described previously (Hirose et al., 2000) .
Measurement of spinal cord tissue levels of CGRP
Spinal cord tissue levels of CGRP were determined by modification of the methods as described previously (Kitamura et al., 2007) . In brief, the frozen sample was weighed and homogenized (1:10, w/v) in 2N acetic acid. The homogenates were bathed in 90°C water for 20 min and then centrifuged (4500 x g at 4°C for 20 minutes). CGRP was extracted from the supernatant using reverse phase C 18 columns (Amersham, Buckinghamshire, England).
Columns were prepared by washing with 5 mL of methanol, followed by 10 mL of water, before use. The supernatant was applied onto the column, followed by washing with 20 mL of 0.1% trifluoroacetic acid. CGRP was eluted with 3 mL of 60% acetonitrile in 0.1% trifluoroacetic acid and the solvent was evaporated under a stream of nitrogen gas. The concentration of CGRP was assayed using a specific enzyme immunoassay kit (SPI-BIO, Massy Cedex, France). The sensitivity of the CGRP assay was 10 picograms/ml. The crossreactivty of the antiserum of rat α-and β-CGRP was 100% as specified in the manufacturer's data sheet. Results are expressed as picograms of CGRP per gram of tissue.
Assay of Levels of 6-keto-PGF 1α in Spinal Cord Tissue
Spinal cord tissue levels of 6-keto-PGF 1α , a stable metabolite of PGI 2 , were determined by modification of the methods as described previously (Hirose et al., 2004) . In brief, the frozen sample was weighed and homogenized (1:10, w/v) in 0.1 M phosphate buffer (pH 7.4) containing 2 mM indomethacin at 4°C. The homogenates were centrifuged at 4500 x g for 20
This article has not been copyedited and formatted. The final version may differ from this version. 16 min at 4°C. The supernatant was then acidified with 1 M HCl. 6-keto-PGF 1α was extracted from the supernatant using columns packed with ethyl-bonded silica gel (ethyl C 2 , Amersham, Buckinghamshire, UK). Columns were prepared by washing with 2 mL of methanol, followed by 2 mL of water, prior to use. The acidified supernatant was applied onto the column, followed by washing sequentially with 5 mL of 10% ethanol and 5 mL of hexane. 6-keto-PGF 1α was eluted with 5 mL of methyl formate, and the solvent was evaporated under a stream of nitrogen gas. The concentration of 6-keto-PGF 1α was assayed using a specific enzyme immunoassay kit (Amersham, Buckinghamshire, UK). The cross reactivities of this assay with PGE 2 , PGF 2α , thromboxane B 2 , and arachidonic acid were 2.8%, 1.4%, 0.03%, and 0.01%, respectively, according to the manufacturer's data sheet. Results are expressed as ng of 6-keto-PGF 1α per gram of tissue. We measured the spinal cord 6-keto-PGF 1α levels 3 hours after reperfusion as described previously (Hirose et al., 2004) .
Statistical Analysis
All values are expressed as mean ± standard deviation. Survival rate was analyzed with
Fisher's exact probability test. Differences in motor scores were assessed using the 
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Results
Effect of ANP on CGRP release and cellular cAMP levels in DRG isolated from rats in vitro
To determine whether ANP increases CGRP release from sensory neurons, we examined the effect of ANP on CGRP release from DRG isolated from rats. ANP, at concentrations higher than 1 nM, enhanced CGRP release from DRG (Fig. 1A) . Cyclic AMP has been shown to play an important role in CGRP release from sensory neurons on activation (Mohapatra and Nau, 2003) . ANP, at concentrations higher than 1 nM, increased cellular cAMP levels in DRG isolated from rats (Fig. 1B) . 19 reversed by pretreatment with KT 5720.
Effect of ANP on survival and motor disturbances in rats subjected to spinal cord I/R
To examine whether ANP reduces I/R-induced SCI in rats, we analyzed the effect of ANP on motor disturbances observed in rats subjected to spinal cord I/R. Although intravenous administration of ANP at a dosage of 1 µg/kg/min significantly reduced motor disturbances, ANP at dosages of 0.1 and 0.5 µg/kg/min did not (data not shown). Thus, we examined the therapeutic mechanism of ANP at a dosage of 1 µg/kg/min on I/R-induced SCI in rats in the present study. The overall survival rate at 21 days after aortic occlusion was significantly higher in ANP-treated SCI animals (n=10) (80%) than in saline-treated SCI animals (n=10) (20%, p<0.03) (Fig. 3) . Although saline-treated SCI animals showed remarkable neurologic dysfunction and did not show recovery from paralysis, the neurologic scores (Tarlov's score) of ANP-treated SCI animals (n=10) did not decrease and were significantly higher each day for 7 days than those of saline-treated SCI animals (n=10) (p<0.01) (Fig. 4) . The angle of the inclined plane was higher in ANP-treated SCI animals (n=10) than that in saline-treated SCI animals (n=10) at 24 hours after reperfusion (Fig. 5) . In contrast to results in animals administered ANP prior to spinal cord I/R, motor disturbances were not reduced in animals administered ANP (1 µg/kg/min for 90 min) at 15 min after the spinal cord I/R (data not shown).
Effect of ANP on I/R-induced histopathologic changes in the spinal cord tissue.
20
There were no histopathologic changes in spinal cord tissue sections from sham-operated animals ( Fig. 6 , inset A). Nissl's substance was observed in the cytoplasm of normal neurons in these animals (Fig. 6, inset A) . In contrast, spinal cord tissue sections from saline-treated SCI animals showed neuronal injury in the ventral gray matter; i.e. many neurons were characterized by eosinophilic, structureless cytoplasm and loss of nuclear hematoxylin stainability (Fig. 6, inset B) . The tissue sections from ANP-treated SCI animals showed a marked reduction of these histopathologic changes (Fig. 6, inset C) . Although approximately 70% of motor neurons in the ventral grey matter were lost in saline-treated SCI animals, only about 25% of motor neurons were lost in ANP-treated SCI animals (Fig. 6 ).
Effect of ANP on spinal cord tissue levels of CGRP in rats subjected to spinal cord I/R.
To examine whether ANP reduces I/R-induced SCI by sensory neuron activation in rats, we analyzed the effect of ANP on spinal cord tissue levels of CGRP in rats subjected to spinal cord I/R. Spinal cord tissue levels of CGRP were significantly increased after spinal cord I/R, peaking at 1 hour after reperfusion, compared with those in sham-operated animals (Fig. 7A ).
ANP markedly enhanced I/R-induced increases in spinal cord tissue levels of CGRP at 1 hour after reperfusion (Fig. 7B ).
Effect of ANP on spinal cord tissue levels of 6-keto-PGF 1α , TNF and MPO in rats
This article has not been copyedited and formatted. The final version may differ from this version. at 1 hour after reperfusion (Fig. 8A) .
Spinal cord tissue levels of TNF were increased after spinal cord I/R, peaking at 3 hours after reperfusion (Hirose et al., 2000) . Administration of ANP inhibited I/R-induced increases in spinal cord tissue levels of TNF at 3 hours after reperfusion (Fig. 8B ).
Accumulation of neutrophils in the post-ischemic spinal cord tissue was evaluated by measuring MPO levels. Spinal cord tissue levels of MPO were increased after spinal cord I/R, peaking at 24 hours after reperfusion (Hirose et al., 2000) . ANP significantly inhibited increases in MPO levels at 24 hours after reperfusion (Fig. 8C) . 22 of motor disturbances in rats subjected to spinal cord I/R. Although pretreatment with SB366791 did not exacerbate motor disturbances, it completely reversed ANP-induced reduction of motor disturbances in animals subjected to spinal cord I/R (Fig. 5) . We previously reported that CGRP increases endothelial PGI 2 production, thereby reducing tissue injury through attenuation of inflammatory responses in rats (Harada et al., 2002) . Thus, it is possible that PGI 2 is critically involved in therapeutic effects of ANP in rats subjected to spinal cord I/R.
Effects of ANP
To examine this possibility, we analyzed the effect of pretreatment with IM on ANP-induced reduction of motor disturbances in rats subjected to spinal cord I/R. Although pretreatment with IM did not exacerbate motor disturbances, it completely reversed ANP-induced reduction of motor disturbances in animals subjected to spinal cord I/R (Fig. 5) .
Effects of ANP and/or SB366791 on increases in spinal cord tissue levels of CGRP in rats subjected to spinal cord I/R.
Pretreatment with SB366791 inhibited I/R-induced increases in spinal cord tissue levels of CGRP and it also completely inhibited ANP-induced increases in spinal cord tissue levels of CGRP at 1 hour after reperfusion (Fig. 7B) . Thus, sensory neuron activation might play a critical role in ANP-induced enhancement of spinal cord tissue levels of CGRP in rats subjected to spinal cord I/R.
Effects of ANP, SB366791 and/or IM on spinal cord tissue levels of 6-keto-PGF 1α

, TNF
Pretreatment with SB366791 and IM inhibited I/R-induced increases in spinal cord
tissue levels of 6-keto-PGF 1α and it also completely reversed ANP-induced enhancement of increases in spinal cord tissue levels of 6-keto-PGF 1α in rats subjected to spinal cord I/R (Fig.   8A ).
Pretreatment with SB366791 and IM had no effects on I/R-induced increases in spinal cord tissue levels of TNF and MPO (Fig. 8 , B and C). However, ANP-induced effects on spinal cord tissue levels of TNF and MPO in rats subjected to spinal cord I/R were completely abrogated by pretreatment with SB366791 and IM (Fig. 8, B 
and C).
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Discussion
In the present study, ANP increased CGRP release from DRG isolated from rats in vitro.
To examine whether ANP increases CGRP release by activating vanilloid receptor-1 in sensory neurons in vitro, we analyzed the effect of SB366791, a vanilloid receptor-1 inhibitor more specific than CPZ (Varga et al., 2005) , on the ANP-induced increase in CGRP release from isolated DRG. However, preliminary experiments showed that SB366791 increased CGRP release from DRG isolated from rats and this effect might be induced by dimethyl sulfoxide present in SB366791 solution (data not shown). Thus, we used CPZ instead of SB366791 for in vitro experiments in the present study. Pretreatment with CPZ reversed the ANP-induced increase in CGRP release from DRG, suggesting that vanilloid receptor-1 activation might be critically involved in the ANP-induced increase in CGRP release from sensory neurons.
However, the mechanism(s) by which ANP activates vanilloid receptor-1 is still not fully understood. ANP activates PKA in the ischemic liver of rats, thereby preventing apoptosis 28 local inflammatory responses in rats subjected to compression trauma-induced spinal cord injury only when the motor disturbances and local inflammatory responses were maximum (Kitamura et al., 2007) . Thus, it is likely that motor disturbances and local inflammatory responses observed in rats subjected to milder spinal cord ischemia are exacerbated by pretreatment with SB366791 and IM.
Since PGE 2 is synthesized in endothelial cells from PGH 2 , a common precursor of PGI 2 , (Gerritsen and Cheli, 1983) , it is likely that sensory neuron activation increases endothelial production of PGE 2 as well as PGI 2 . Consistent with this hypothesis is our previous report demonstrating that sensory neuron activation increases gastric tissue levels of PGE 2 as well as 6-keto-PGF 1α , thereby attenuating local inflammatory responses in rats subjected to stress (Harada et al., 2003) . Thus, it is likely that ANP increases the endothelial production of both PGE 2 and PGI 2 by increasing CGRP release from sensory neurons, thereby reducing SCI through attenuation of inflammatory responses in rats subjected to spinal cord I/R. sham-operated animals; *, p<0.01 vs. saline-treated SCI animals (SCI + Saline). sham-operated animals; *, p<0.01 vs. saline-treated SCI animals (SCI + Saline); †, p<0.01 vs.
ANP-treated SCI animals (SCI + ANP). ANP (1 µg/kg/min) was intravenously administered from 30 minutes before ischemia to 60 minutes after reperfusion. SB (500 µg/kg) was administered intraperitoneally at 30 minutes before ischemia. IM (20 mg/kg) was administered subcutaneously at 60 minutes before ischemia. Spinal cord tissue levels of 6-keto-PGF 1α , TNF, and MPO were determined at 1, 3, and 24 hours after reperfusion, respectively. Data are expressed as the mean ± standard deviation from 5 animal experiments. §, p<0.01 vs. sham-operated animals; *, p<0.01 vs.
saline-treated SCI animals (SCI + Saline); †, p<0.01 vs. ANP-treated SCI animals (SCI + ANP).
